share_log

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

PR Newswire ·  Apr 1 21:00
DELFI Diagnostics, Inc. (PRNewsfoto/DELFI Diagnostics)
FirstLook Lung is a new blood test that offers a convenient, accessible, and personalized approach to enhance lung cancer screening. FirstLook helps determine the likelihood of detecting lung cancer through low-dose CT (LDCT), with a negative predictive value of 99.8%.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment